122 related articles for article (PubMed ID: 2190660)
41. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Petersen FB; Appelbaum FR; Bigelow CL; Buckner CD; Clift RA; Sanders JE; Storb R; Sullivan KM; Weiden PL; Fefer A
Bone Marrow Transplant; 1989 Sep; 4(5):483-8. PubMed ID: 2676043
[TBL] [Abstract][Full Text] [Related]
42. Autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: the Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation.
Yahalom J; Gulati S
Ann Oncol; 1991 Feb; 2 Suppl 2():67-71. PubMed ID: 2049322
[TBL] [Abstract][Full Text] [Related]
43. Is total body irradiation a necessary component of preparative therapy for autologous transplantation in non-Hodgkin's lymphoma.
Stein RS; Greer JP; Goodman S; Brandt SJ; Morgan DS; Macon WR; McCurley TL; Wolff SN
Leuk Lymphoma; 2001 Mar; 41(1-2):97-103. PubMed ID: 11342361
[TBL] [Abstract][Full Text] [Related]
44. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Riddell S; Appelbaum FR; Buckner CD; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas ED
J Clin Oncol; 1988 Apr; 6(4):576-82. PubMed ID: 3282031
[TBL] [Abstract][Full Text] [Related]
45. High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma.
Lonial S; Jones TW; Devine S; Winton EF; Heffner LT; Smith KJ; Yeager AM; Waller EK
Leuk Lymphoma; 2000 Feb; 36(5-6):497-502. PubMed ID: 10784394
[TBL] [Abstract][Full Text] [Related]
46. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
Bierman PJ; Vose JM; Leichner PK; Quadri SM; Armitage JO; Klein JL; Abrams RA; Dicke KA; Vriesendorp HM
J Clin Oncol; 1993 Apr; 11(4):698-703. PubMed ID: 8478663
[TBL] [Abstract][Full Text] [Related]
47. Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
Gandola L; Siena S; Bregni M; Sverzellati E; Piotti P; Stucchi C; Gianni AM; Lombardi F
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):743-9. PubMed ID: 1976614
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
Petersen FB; Appelbaum FR; Buckner CD; Sanders JE; Clift RA; McGuffin R; Bearman SI; Flournoy N; Thomas ED
Bone Marrow Transplant; 1988 Nov; 3(6):619-24. PubMed ID: 3063329
[TBL] [Abstract][Full Text] [Related]
49. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.
Abrams RA; Liu PJ; Ambinder RF; Haulk TL; Korman LT; Herman MG; Jones RJ
Radiology; 1997 Jun; 203(3):865-70. PubMed ID: 9169718
[TBL] [Abstract][Full Text] [Related]
50. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.
McAfee SL; Powell SN; Colby C; Spitzer TR
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):151-6. PubMed ID: 12007954
[TBL] [Abstract][Full Text] [Related]
51. Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
Gorin NC; Najman A; Douay L; Salmon C; David R; Stachowiak J; Parlier Y; Lopez M; Oppenheimer M; Lecomte D
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):217-25. PubMed ID: 6368242
[TBL] [Abstract][Full Text] [Related]
52. Factors affecting the outcome of autologous bone marrow transplantation.
Gulati SC; Yahalom J; Whitmarsh K; Clarkson BD; Gee T
Ann Oncol; 1991 Jan; 2 Suppl 1():51-5. PubMed ID: 2043499
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation.
Jules-Elysee K; Stover DE; Yahalom J; White DA; Gulati SC
Am Rev Respir Dis; 1992 Aug; 146(2):485-91. PubMed ID: 1489145
[TBL] [Abstract][Full Text] [Related]
54. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
Gopal R; Ha CS; Tucker SL; Khouri IF; Giralt SA; Gajewski JL; Andersson BS; Cox JD; Champlin RE
Cancer; 2001 Oct; 92(7):1949-58. PubMed ID: 11745270
[TBL] [Abstract][Full Text] [Related]
55. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.
Phillips GL; Reece DE
Clin Haematol; 1986 Feb; 15(1):151-66. PubMed ID: 3516487
[TBL] [Abstract][Full Text] [Related]
56. Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Hiddemann W; Schmitz N; Pfreundschuh M; Pflüger KH; Ollech-Chwoyka J; Tirier C; Maschmeyer G; Kirchner H; Wagner T; Koch P
Cancer; 1990 Sep; 66(5):838-43. PubMed ID: 2386912
[TBL] [Abstract][Full Text] [Related]
57. High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphoma.
Tannir NM; Spitzer G; Zander AR; Jagannath S; Kanojia M; Vellekoop L; McLaughlin P; Hagemeister FJ; Dicke KA
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1091-6. PubMed ID: 6352279
[TBL] [Abstract][Full Text] [Related]
58. High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin's lymphoma.
Tura S; Mazza P; Gherlinzoni F; Ricci P; Visani G; Bandini G; Zaccaria A; Rosti G; Lauria F; Baccarani M
Scand J Haematol; 1986 Oct; 37(4):347-52. PubMed ID: 3538369
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
Mulder PO; de Vries EG; Koops HS; Splinter T; Maas A; van der Geest S; Mulder NH; Sleijfer DT
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):675-9. PubMed ID: 2838293
[TBL] [Abstract][Full Text] [Related]
60. Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation.
Salloum E; Jillella AP; Nadkarni R; Seropian S; Hu GL; D'Andrea E; Zelterman D; Cooper DL
Cancer; 1998 Apr; 82(8):1506-12. PubMed ID: 9554528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
